Ravid M - Search Results

1

Losartan and lercanidipine attenuate low-density lipoprotein oxidation in patients with hypertension and type 2 diabetes mellitus: a randomized, prospective crossover study.

Rachmani R, Levi Z, Zadok BS, Ravid M. Rachmani R, et al. Among authors: ravid m. Clin Pharmacol Ther. 2002 Sep;72(3):302-7. doi: 10.1067/mcp.2002.127110. Clin Pharmacol Ther. 2002. PMID: 12235451 Clinical Trial.

2

Oxidation of low-density lipoprotein in normotensive type 2 diabetic patients. Comparative effects of enalapril versus nifedipine: a randomized cross-over over study.

Rachmani R, Lidar M, Brosh D, Levi Z, Ravid M. Rachmani R, et al. Among authors: ravid m. Diabetes Res Clin Pract. 2000 May;48(2):139-45. doi: 10.1016/s0168-8227(99)00149-7. Diabetes Res Clin Pract. 2000. PMID: 10802151 Clinical Trial.

3

Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with Type 2 diabetes mellitus--a randomized prospective study.

Rachmani R, Levi Z, Slavachevski I, Avin M, Ravid M. Rachmani R, et al. Among authors: ravid m. Diabet Med. 2002 May;19(5):385-92. doi: 10.1046/j.1464-5491.2002.00701.x. Diabet Med. 2002. PMID: 12027926 Clinical Trial.

4

Effect of an alpha-adrenergic blocker, and ACE inhibitor and hydrochlorothiazide on blood pressure and on renal function in type 2 diabetic patients with hypertension and albuminuria. A randomized cross-over study.

Rachmani R, Levi Z, Slavachevsky I, Half-Onn E, Ravid M. Rachmani R, et al. Among authors: ravid m. Nephron. 1998 Oct;80(2):175-82. doi: 10.1159/000045163. Nephron. 1998. PMID: 9736816 Clinical Trial.

5

Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications.

Rachmani R, Slavachevski I, Levi Z, Zadok B, Kedar Y, Ravid M. Rachmani R, et al. Among authors: ravid m. Eur J Intern Med. 2002 Oct;13(7):428. doi: 10.1016/s0953-6205(02)00131-0. Eur J Intern Med. 2002. PMID: 12384131

6

Use of a mild sedative helps to identify true non-dippers by ABPM: a study in patients with diabetes mellitus and hypertension.

Rachmani R, Shenhav G, Slavachevsky I, Levy Z, Ravid M. Rachmani R, et al. Among authors: ravid m. Blood Press Monit. 2004 Apr;9(2):65-9. doi: 10.1097/00126097-200404000-00002. Blood Press Monit. 2004. PMID: 15096902 Clinical Trial.

7

Treatment of high-risk patients with diabetes: motivation and teaching intervention: a randomized, prospective 8-year follow-up study.

Rachmani R, Slavacheski I, Berla M, Frommer-Shapira R, Ravid M. Rachmani R, et al. Among authors: ravid m. J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S22-6. doi: 10.1681/asn.2004110965. J Am Soc Nephrol. 2005. PMID: 15938028 Clinical Trial.

8

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Ravid M, et al. Among authors: ravid safran d. Arch Intern Med. 1998 May 11;158(9):998-1004. doi: 10.1001/archinte.158.9.998. Arch Intern Med. 1998. PMID: 9588433

9

Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R. Ravid M, et al. Among authors: ravid d. Ann Intern Med. 1998 Jun 15;128(12 Pt 1):982-8. doi: 10.7326/0003-4819-128-12_part_1-199806150-00004. Ann Intern Med. 1998. PMID: 9625684 Clinical Trial.

10

Risk factors for nephropathy in type 2 diabetes mellitus.

Rachmani R, Ravid M. Rachmani R, et al. Among authors: ravid m. Compr Ther. 1999 Jun-Jul;25(6-7):366-9. doi: 10.1007/BF02944283. Compr Ther. 1999. PMID: 10470521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters